Possible Inhibitory Effect of Erythropoiesis-Stimulating Agents at the Predialysis Stage on Early-Phase Coronary Events after Hemodialysis Initiation

Masato Nishimura,Keitaro Watanabe,Yuki Kitamura,Takao Nagashima,Toshiko Tokoro,Toru Takatani,Nodoka Sato,Satoru Yamazaki,Tetsuya Hashimoto,Hiroyuki Kobayashi,Toshihiko Ono

Possible Inhibitory Effect of Erythropoiesis-Stimulating Agents at the Predialysis Stage on Early-Phase Coronary Events after Hemodialysis Initiation

2017

Masato Nishimura
Keitaro Watanabe
Yuki Kitamura
Takao Nagashima
Toshiko Tokoro
Toru Takatani
Nodoka Sato
Satoru Yamazaki
Tetsuya Hashimoto
Hiroyuki Kobayashi
Toshihiko Ono

Background: We examined whether the use of erythropoiesis-stimulating agents (ESAs) to correct anemia at the predialysis stage could inhibit early-phase coronary

Keywords:

Diabetes mellitus
Cardiology
Internal medicine
Erythropoiesis
Anemia
Hemodialysis
Medicine
Erythropoiesis-stimulating agent
early phase
inhibitory effect
coronary plaque

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations